Article
Design and development of a urinary cell pellet mRNA PCR-based assay for progressive kidney disease: Nephro-Dx
2025-11-02
Abstract excerpt
Progressive chronic kidney disease (CKD) is a major source of public health spending. Current non-invasive tests estimate CKD but provide a minimal understanding of cell- or compartment-specific injury. The gold standard for CKD diagnosis is a kidney biopsy, which affords risks and is impractical to repeat multiple times. Hence, repeatable, non-invasive tests to estimate pathologic kidney injury for diagnoses, pro...
Topics
Open a Topic to create a Post that cites this publication.
- Biosimilars and Bioanalytical Methods
- Chronic Kidney Disease and Diabetes
- Cytomegalovirus and herpesvirus research
- Organ Transplantation Techniques and Outcomes
- Renal and Vascular Pathologies
- Renal Diseases and Glomerulopathies
- Renal Transplantation Outcomes and Treatments
- Single-cell and spatial transcriptomics
Identifiers and source
- Literature Corpus work
- df6b35a1-2a00-5172-bdc5-d4fe00241f4f
- DOI
- 10.1101/2025.10.31.25338655
